Nutex Capex To Revenue from 2010 to 2024

NUTX Stock  USD 32.91  1.02  3.20%   
Nutex Health Capex To Revenue yearly trend continues to be fairly stable with very little volatility. Capex To Revenue will likely drop to 0.04 in 2024. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.03834837
Current Value
0.0364
Quarterly Volatility
0.14475817
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 26.3 M, Total Revenue of 129 M or Gross Profit of 54.7 M, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0037 or PTB Ratio of 1.84. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.
  
Check out the analysis of Nutex Health Correlation against competitors.
For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

Latest Nutex Health's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Nutex Health over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Nutex Health's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Pretty Stable
   Capex To Revenue   
       Timeline  

Nutex Capex To Revenue Regression Statistics

Arithmetic Mean0.21
Geometric Mean0.12
Coefficient Of Variation68.95
Mean Deviation0.13
Median0.33
Standard Deviation0.14
Sample Variance0.02
Range0.328
R-Value(0.24)
Mean Square Error0.02
R-Squared0.06
Significance0.40
Slope(0.01)
Total Sum of Squares0.29

Nutex Capex To Revenue History

2024 0.0364
2023 0.0383
2022 0.0667
2021 0.11
2020 0.22
2012 0.33
2011 0.007608

About Nutex Health Financial Statements

Nutex Health investors use historical fundamental indicators, such as Nutex Health's Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Revenue 0.04  0.04 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.